Biotechnology

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, the team has empowered exceptional entrepreneurs through capital, expertise, and market access, focusing on large unmet patient needs in chronic diseases, particularly cardio & neurovascular disorders.

The corporate venture arm of AbbVie, investing in novel, transformational therapeutics at discovery and preclinical stages.

Altitude Life Science Ventures is a venture capital firm investing in early-stage life science companies. They focus on markets with strong demand and growth potential, and then back the highest-quality entrepreneurs.

Alumni Ventures is a network-powered venture capital firm providing access to professionally-managed, diversified venture portfolios for accredited investors and institutions. Its large and well-connected network fuels deal flow and value-added services to portfolio companies.

Atlas Venture builds breakthrough biotechnology companies, partnering with leading life science entrepreneurs to translate groundbreaking science into life-changing medicines. With over 30 years of experience, they have a strong track record of launching startups and achieving successful exits.

BEAST invests in Breakthrough Engineering, Applied Science and Technology startups across the UK and Continental Europe at the Seed stage. They focus on deep, frontier technologies with potential for health, climate, or societal impact, backing founders from inception and supporting growth.

Better Ventures is a mission-driven venture capital firm investing in technology companies building a better world. They focus on B2B solutions leveraging AI/ML, software, materials science, and biotechnology, prioritizing companies addressing the UN's Sustainable Development Goals.

The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation. It invests in pioneering science with the potential for significant patient benefit, focusing on areas like immunology, regenerative medicine, and digital health. The fund provides financial support and strategic guidance to portfolio companies.

BoxOne Ventures is a privately held investment firm focusing on early-stage companies in impactful, fast-changing sectors. They invest their own capital and support entrepreneurs from early stages to IPO, partnering closely but without hindering their progress. Their areas of interest include biotechnology, the future of food, and technologies improving quality of life.

Breakout Ventures invests in early-stage companies building bio-based solutions to improve human health and sustainability. They support companies from seed to scale, providing resources and a network to help them reach critical milestones. Their focus is on creative bioscience entrepreneurs building the future.

Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investments. They leverage the partners' deep operating experience and successful investment background, primarily investing in technology and life sciences sectors.

Casdin Capital invests in all aspects of the life sciences revolution, partnering with companies across Healthcare, Biotechnology, Synthetic Biology, and Technology. Their investment strategy focuses on big markets, great ideas, strong teams, and a long-term perspective. They aim to create value and open new opportunities through patience and strong relationships.